Business ❯ Pharmaceuticals

Vaccine Manufacturers

Moderna Pfizer Merck Indian Companies Biontech Market Impact Market Access Pfizer, Novavax, Moderna Market Reactions Stock Market Moderna, Inc.

Pfizer and BioNTech Halt U.S. COVID Vaccine Trial for 50–64-Year-Olds Over Slow Enrollment

Tougher FDA rules are squeezing efforts to test shots in healthy adults 50 to 64.

Vaccine Stocks Slide After FDA Memo Alleging Child Deaths and Tougher Approval Standards